Bladder cancer

Preferred Label : Bladder cancer;

Type : Phenotype, molecular basis known;

Inheritance : Somatic mutation;

Molecular basis : Caused by somatic mutation in the KRAS protooncogene, GTPase, gene (KRAS, 190070.0002); Caused by somatic mutation in the fibroblast growth factor receptor 3 gene (FGFR3, 134934.0013); Caused by somatic mutation in the RB transcriptional corepressor 1 gene (RB1, 614041.0009); Caused by somatic mutation in the HRAS protooncogene, GTPase, gene (HRAS, 190020.0001);

Neoplasia : Transitional cell bladder carcinoma; Bladder cancer;

Prefixed ID : #109800;

Details

Origin ID

109800;

UMLS CUI

C0005684;

Automatic exact mappings (from CISMeF team)
- Bladder Cancer Pathway [NCIt concept]
- Childhood Bladder Carcinoma [NCIt concept]
- Malignant neoplasm of other specified sites of bladder [ICD-9 code]
Currated CISMeF NLP mapping
- BLADDER CARCINOMA [WHO-ART Preferred Term]
- Bladder Carcinoma [NCIt concept]
- Bladder cancer [PASCAL descriptor]
- Bladder cancer [HPMULTI term]
- Bladder cancer [MedDRA Preferred Term]
- Bladder cancer [ORDO Disease]
- Bladder cancer NOS [MedDRA LLT]
- Bladder carcinoma [HPO term]
- Bladder neoplasm [HPO term]
- Carcinoma of bladder (disorder) [SNOMED CT concept]
- Malignant Bladder Neoplasm [NCIt concept]
- Malignant neoplasm of bladder [ICD-10 category (who)]
- Malignant neoplasm of bladder, part unspecified [ICD-9 code]
- Malignant neoplasms of bladder [ICD-11 Category]
- Malignant tumor of urinary bladder (disorder) [SNOMED CT concept]
- bladder cancer [MedlinePlus Topic]
- malignant neoplasm of bladder [ICPC-2 Rubric]
- urinary bladder cancer [DO Concept]
- urinary bladder cancer [MeSH concept]
- urinary bladder neoplasms [MeSH Descriptor]
DO Cross reference
- urinary bladder cancer [DO Concept]
Genes related to phenotype
- Fibroblast growth factor receptor 3 [OMIM gene]
- Hras protooncogene, gtpase [OMIM gene]
- Kras protooncogene, gtpase [OMIM gene]
- Rb transcriptional corepressor 1 [OMIM gene]
HPO term(s)
- Autosomal dominant inheritance [HPO term]
- Somatic mutation [HPO term]
- Transitional cell carcinoma of the bladder [HPO term]
ORDO concept(s)
- Bladder cancer [ORDO Disease]
Semantic type(s)
- Neoplastic Process [UMLS semantic type]
UMLS correspondences (same concept)
- Bladder cancer [MedDRA Preferred Term]
- Bladder cancer NOS [MedDRA LLT]
- Bladder neoplasms malignant [MedDRA High Level Term]
- Malignant Bladder Neoplasm [NCIt concept]
- Malignant neoplasm of bladder [ICD-10 category (who)]
- Malignant neoplasm of bladder [MedDRA LLT]
- Malignant neoplasm of bladder [ICD-10 category]
- Malignant neoplasm of bladder [ICD-9 code]
- Malignant neoplasm of bladder, part unspecified [MedDRA LLT]
- Malignant neoplasm of bladder, part unspecified [ICD-9 code]
- Malignant neoplasm of bladder, unspecified [ICD-10 Sub-category]
- Malignant tumor of urinary bladder (disorder) [SNOMED CT concept]
- bladder cancer [MedlinePlus Topic]
- malignant neoplasm of bladder [ICPC-2 Rubric]
- malignant neoplasm of bladder, nos [SNOMED Notion]
- urinary bladder cancer [MeSH concept]
- urinary bladder cancer [Disease (Nov.)]
Validated automatic mappings to BTNT
- urinary bladder cancer [Disease (Nov.)]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients